APAC
Lipid nanoparticles market to reach $3.1b by 2033 as chronic diseases rise
Lipid nanoparticles market to reach $3.1b by 2033 as chronic diseases rise
The adoption of mRNA-based vaccines will also fuel demand.
2 days ago
Reproductive health disorders to drive female tech market to $26.1b by 2033
It will expand at a compound annual growth rate of 15.2%.
2 days ago
Nanomedicine market poised for double-digit growth
It is driven by the rising prevalence of chronic diseases.
2 days ago
Neurological disorders and aging boost brain-computer interface market
Government and private investment accelerates innovation.
3 days ago
AI and mobile integration drive surge in smart inhaler adoptions
Rising need for personalised and remote healthcare also drives adoption.
3 days ago
Structural heart devices market to reach $2.93b by 2032
Asia Pacific is the fastest-growing region with a 10.0% CAGR.
3 days ago
Rising CKD cases and advanced biomarkers fuel $4.8b market growth
Market growth is expected to continue through 2034.
4 days ago
Global prescription drugs market to reach $2.26t by 2034
The Asia Pacific region is projected to register the fastest growth rate.
5 days ago
Rising cases, advanced diagnostics drive biliary tract cancer market growth across 7MM
Increasing cases were driven by aging populations and liver diseases.
5 days ago
How quickly can hospitals expand ICU and acute-care beds to meet rising demand?
A staffing shortage makes it harder to turn added space into fully usable beds.
6 days ago
Rising demand for advanced surgical devices to push market to $27.4b by 2032
Robotic-assisted surgery drives precision in complex procedures.
6 days ago
Automation, continuous manufacturing drive global pharmaceutical equipment demand
It is also driven by chronic diseases and biologics production.
Aging population drives demand for durable medical equipment market
Telehealth, 3D printing, and customisation are amongst the key trends.
Pureland Venture’s Chris Hardesty: Governments must sustain long-term focus on healthcare innovation, technology
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Infectious diseases, fast diagnostics drive clinical microbiology market
Asia-Pacific will see the fastest growth.
SLE, lupus nephritis market to more than double by 2034
It will be driven by nine new pipeline therapies targeting disease modification
NSAIDs and opioids dominate global pain therapeutics market
Regulatory incentives and innovative trial designs also boost market interest.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation